Oppilotech have developed a unique high-resolution platform based on systems biology and machine learning to model biological processes in cells. The platform is utilized to identify first-in-class viable drug targets and to develop novel modes of action drugs modulating the identified targets. Three first-in-class antibacterial drug targets and generated active chemical matter against 2 of them.
Status | Active |
Website | http://oppilotech.com/ |
Category | AI & Biotech |
Modality | Small Molecule |
Headquaters | London, UK |
Partner | Innovate UK Babraham Accelrator Francis Crick Institute |
Investment Portfolio | Pre-Fund Investment |